Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideIDXXIdexx Laboratories
FinDog View：Bullish
| Metric | ABBV | IDXX |
|---|
| Close | 294.89 | 551.21 |
| Market Cap | $522B | $43.9B |
| 1M | +12.73% | +5.56% |
| P/E (TTM) | 81.4 | 38.9 |
| Forward P/E | 16.9 | 32.2 |
| P/E 5-Yr Percentile | 62 | 7 |
| P/S | 8.0 | 9.8 |
| P/B | — | 27.5 |
| Dividend Yield | 4.47% | — |
| Latest Quarter Revenue | $17.0B | $1.2B |
| Revenue YoY | +10.2% | +9.7% |
| Gross Margin | 74.7% | 64.0% |
| Latest Quarter EPS | 2.03 | 4.27 |
| Avg Post-Earnings Move | ±1.7% | ±1.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.58% | 2.68% |
| 90-Day Net Insider Buying | −$8.2M | −$1.2M |
ABBV · Revenue, Last 8 Quarters ($B)
IDXX · Revenue, Last 8 Quarters ($B)
